Efficacy and safety of once-weekly insulin icodec compared to once-daily insulin g U-100 in patients with type II diabetes: a systematic review and meta-analysis

Diabetes affects millions of people globally, despite treatment options, adherence and other factors pose obstacles. Once-weekly Insulin Icodec, a novel basal Insulin analog with a week-long half-life, offers ...

Source: Diabetology and Metabolic Syndrome - April 3, 2024 Category: Endocrinology Authors: Syed Zia Saleem, Areeba Fareed, Syed Muhammad Muneeb Akhtar, Solay Farhat, Amira Mohamed Taha and Aymar Akilimali Tags: Review Source Type: research